• 01:28 1.
    index 1
  • 03:41 2.
    CircRNA-SORE was overexpressed in sorafenib-resistant HCC cells
  • 00:07 3.
    CircRNA-SORE was overexpressed in sorafenib-resistant HCC cells
  • 01:51 4.
    CircRNA-SORE was overexpressed in sorafenib-resistant HCC cells
  • 03:54 5.
    CircRNA-SORE was overexpressed in sorafenib-resistant HCC cells
  • 00:33 6.
    CircRNA-SORE was critical for maintaining sorafenib resistance
  • 02:43 7.
    CircRNA-SORE was critical for maintaining sorafenib resistance
  • 02:24 8.
    CircRNA-SORE was critical for maintaining sorafenib resistance
  • 01:22 9.
    CircRNA-SORE was critical for maintaining sorafenib resistance
  • 00:04 10.
    CircRNA-SORE functioned by binding to YBX1 protein
  • 00:12 11.
    CircRNA-SORE was critical for maintaining sorafenib resistance
  • 04:52 12.
    CircRNA-SORE functioned by binding to YBX1 protein
  • 04:35 13.
    CircRNA-SORE functioned by binding to YBX1 protein
  • 02:46 14.
    CircRNA-SORE functioned by binding to YBX1 protein
  • 02:03 15.
    CircRNA-SORE functioned by binding to YBX1 protein
  • 00:32 16.
    CircRNA-SORE functioned by binding to YBX1 protein
  • 00:04 17.
    CircRNA-SORE functioned by binding to YBX1 protein
  • 00:36 18.
    CircRNA-SORE functioned by binding to YBX1 protein
  • 08:48 19.
    Patients with lower circRNA-SORE or YBX1 expression were associated with better recurrence-free survival
  • 04:23 20.
    CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
  • 00:50 21.
    CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
  • 02:42 22.
    CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
  • 01:14 23.
    CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
  • 02:47 24.
    CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
  • 04:29 25.
    CircRNA-SORE transmited sorafenib resistance by exosomes
  • 05:58 26.
    CircRNA-SORE transmited sorafenib resistance by exosomes
  • 00:15 27.
    Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
  • 00:01 28.
    CircRNA-SORE transmited sorafenib resistance by exosomes
  • 00:19 29.
    ** after 20221121.pptx
  • 00:31 30.
    CircRNA-SORE transmited sorafenib resistance by exosomes
  • 00:02 31.
    Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
  • 00:04 32.
    ** after 20221121.pptx
  • 02:05 33.
    Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
  • 00:15 34.
    Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
  • 00:35 35.
    Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
  • 00:08 36.
    Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
  • 00:03 37.
    Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
  • 00:05 38.
    Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
  • 02:20 39.
    Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
  • 00:10 40.
    Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
  • 04:42 41.
    Conclusion
  • 00:02 42.
    ** after 20221121.pptx
  • Index
  • Notes
  • Comment
  • Fullscreen
20221121_lab meeting_怡君
Duration: 1:16:56, Browse: 82, Last Updated: 2022-11-21
Attachment(s):
    Prev Next
    • 01:28 1.
      index 1
    • 03:41 2.
      CircRNA-SORE was overexpressed in sorafenib-resistant HCC cells
    • 00:07 3.
      CircRNA-SORE was overexpressed in sorafenib-resistant HCC cells
    • 01:51 4.
      CircRNA-SORE was overexpressed in sorafenib-resistant HCC cells
    • 03:54 5.
      CircRNA-SORE was overexpressed in sorafenib-resistant HCC cells
    • 00:33 6.
      CircRNA-SORE was critical for maintaining sorafenib resistance
    • 02:43 7.
      CircRNA-SORE was critical for maintaining sorafenib resistance
    • 02:24 8.
      CircRNA-SORE was critical for maintaining sorafenib resistance
    • 01:22 9.
      CircRNA-SORE was critical for maintaining sorafenib resistance
    • 00:04 10.
      CircRNA-SORE functioned by binding to YBX1 protein
    • 00:12 11.
      CircRNA-SORE was critical for maintaining sorafenib resistance
    • 04:52 12.
      CircRNA-SORE functioned by binding to YBX1 protein
    • 04:35 13.
      CircRNA-SORE functioned by binding to YBX1 protein
    • 02:46 14.
      CircRNA-SORE functioned by binding to YBX1 protein
    • 02:03 15.
      CircRNA-SORE functioned by binding to YBX1 protein
    • 00:32 16.
      CircRNA-SORE functioned by binding to YBX1 protein
    • 00:04 17.
      CircRNA-SORE functioned by binding to YBX1 protein
    • 00:36 18.
      CircRNA-SORE functioned by binding to YBX1 protein
    • 08:48 19.
      Patients with lower circRNA-SORE or YBX1 expression were associated with better recurrence-free survival
    • 04:23 20.
      CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
    • 00:50 21.
      CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
    • 02:42 22.
      CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
    • 01:14 23.
      CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
    • 02:47 24.
      CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
    • 04:29 25.
      CircRNA-SORE transmited sorafenib resistance by exosomes
    • 05:58 26.
      CircRNA-SORE transmited sorafenib resistance by exosomes
    • 00:15 27.
      Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
    • 00:01 28.
      CircRNA-SORE transmited sorafenib resistance by exosomes
    • 00:19 29.
      ** after 20221121.pptx
    • 00:31 30.
      CircRNA-SORE transmited sorafenib resistance by exosomes
    • 00:02 31.
      Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
    • 00:04 32.
      ** after 20221121.pptx
    • 02:05 33.
      Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
    • 00:15 34.
      Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
    • 00:35 35.
      Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
    • 00:08 36.
      Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
    • 00:03 37.
      Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
    • 00:05 38.
      Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
    • 02:20 39.
      Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
    • 00:10 40.
      Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
    • 04:42 41.
      Conclusion
    • 00:02 42.
      ** after 20221121.pptx
    Location
    1. Media Center
    2. ...
    3. 2022
    Folder name
    2022
    Author
    林俐妤
    Branch
    賴亮全教授
    Created
    2022-11-21 10:48:23
    Last Updated
    2022-11-21 11:11:55
    Browse
    82
    Duration
    1:16:56

    臺北市仁愛路一段1號10樓1009室

    R1009 10F No1 Sec1 Ren-Ai Rd, Taipei 100233, Taiwan.

    E-mail: llai@ntu.edu.tw

    Tel: 886-2-2312-3456 # 288241

    Lab: 886-2-2393-8235